Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G B Baker

Showing results (91-100 of 252) with videos related to

Pageof 26
Sort By:
Neurochemical Research|September 1, 1993
Urinary excretion of bioactive amines and their metabolites in psychiatric patients receiving phenelzineK F McKenna, G B Baker, R T Coutts
Molecular and Chemical Neuropathology|April 1, 1989
Regional monoamine and metabolite levels in a feline brain tumor modelJ Bayens-Simmonds, D P Boisvert, G B Baker
Biochemical Pharmacology|June 15, 1986
Pentafluorobenzenesulfonyl chloride as a sensitive reagent for the rapid gas chromatographic analysis of tranylcypromine in tissues and body fluidsT S Rao, G B Baker, R T Coutts
Brain Research Bulletin|July 1, 1987
N,N-dipropargyl-2-phenylethylamine, a potential prodrug of 2-phenylethylamine: neurochemical and neuropharmacological studies in ratT S Rao, G B Baker, R T Coutts
British Journal of Pharmacology|October 1, 1987
Neuropharmacological and neurochemical properties of N-(2-cyanoethyl)-2-phenylethylamine, a prodrug of 2-phenylethylamineG B Baker, R T Coutts, T S Rao
Neurochemical Research|September 1, 1993
Trace amines and Tourette's syndromeG B Baker, R A Bornstein, V K Yeragani
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|April 7, 2000
Metabolism of N,N-dialkylated amphetamines, including deprenyl, by CYP2D6 expressed in a human cell lineM V Bach, R T Coutts, G B Baker
Cellular and Molecular Neurobiology|June 1, 1995
Chronic administration of the antidepressants phenelzine, desipramine, clomipramine, or maprotiline decreases binding to 5-hydroxytryptamine2A receptors without affecting benzodiazepine binding sites in rat brainK G Todd, D J McManus, G B Baker
The Journal of Neuropsychiatry and Clinical Neurosciences|January 1, 1991
Depression and memory in major depressive disorderR A Bornstein, G B Baker, A B Douglass
Journal of Psychopharmacology (Oxford, England)|February 3, 2012
Neurochemical and some related psychopharmacological aspects of Tourette's syndrome: an updateG B Baker, P R Chokka, R A Bornstein
Pageof 26

Showing results (91-100 of 252) with videos related to

Sort By:
Pageof 26
Neurochemical Research|September 1, 1993
Urinary excretion of bioactive amines and their metabolites in psychiatric patients receiving phenelzineK F McKenna, G B Baker, R T Coutts
Molecular and Chemical Neuropathology|April 1, 1989
Regional monoamine and metabolite levels in a feline brain tumor modelJ Bayens-Simmonds, D P Boisvert, G B Baker
Biochemical Pharmacology|June 15, 1986
Pentafluorobenzenesulfonyl chloride as a sensitive reagent for the rapid gas chromatographic analysis of tranylcypromine in tissues and body fluidsT S Rao, G B Baker, R T Coutts
Brain Research Bulletin|July 1, 1987
N,N-dipropargyl-2-phenylethylamine, a potential prodrug of 2-phenylethylamine: neurochemical and neuropharmacological studies in ratT S Rao, G B Baker, R T Coutts
British Journal of Pharmacology|October 1, 1987
Neuropharmacological and neurochemical properties of N-(2-cyanoethyl)-2-phenylethylamine, a prodrug of 2-phenylethylamineG B Baker, R T Coutts, T S Rao
Neurochemical Research|September 1, 1993
Trace amines and Tourette's syndromeG B Baker, R A Bornstein, V K Yeragani
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|April 7, 2000
Metabolism of N,N-dialkylated amphetamines, including deprenyl, by CYP2D6 expressed in a human cell lineM V Bach, R T Coutts, G B Baker
Cellular and Molecular Neurobiology|June 1, 1995
Chronic administration of the antidepressants phenelzine, desipramine, clomipramine, or maprotiline decreases binding to 5-hydroxytryptamine2A receptors without affecting benzodiazepine binding sites in rat brainK G Todd, D J McManus, G B Baker
The Journal of Neuropsychiatry and Clinical Neurosciences|January 1, 1991
Depression and memory in major depressive disorderR A Bornstein, G B Baker, A B Douglass
Journal of Psychopharmacology (Oxford, England)|February 3, 2012
Neurochemical and some related psychopharmacological aspects of Tourette's syndrome: an updateG B Baker, P R Chokka, R A Bornstein
Pageof 26